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COMMENTARY Open Access
Trialling of an optimal health programme
(OHP) across chronic disease
Chantal F. Ski1,2,3*, David R. Thompson1,2 and David J. Castle1,2,3
Abstract
Population ageing is a worldwide phenomenon, most advanced in developed countries and expected to continue
over the next few decades. As people are surviving longer with age-associated disease and disability, there is an
imperative to identify innovative solutions for an already overburdened health care system. Such innovations need
to be focused on disease management, taking into consideration the strong associations that have been
established between psychosocial factors and pathophysiological mechanisms associated with chronic disease.
Aside from personal and community costs, chronic diseases produce a significant economic burden due to the
culmination of health care costs and lost productivity. This commentary reports on a programme of research,
Translating Research, Integrated Public Health Outcomes and Delivery, which will evaluate an optimal health
programme that adopts a person-centred approach and engages collaborative therapy to educate, support and
improve the psychosocial health of those with chronic disease. The effectiveness of the optimal health programme
will be evaluated across three of the most significant contributors to disease burden: diabetes mellitus, chronic
kidney disease and stroke. Cost-effectiveness will also be evaluated. The findings derived from this series of
randomised controlled trials will also provide evidence attesting to the potential applicability of the optimal health
programme in other chronic conditions.
Keywords: Collaborative therapy, Cost-effectiveness, Chronic disease, Psychoeducational, Psychosocial, Randomised
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Background
Over the past few decades, tremendous advances in
medical science and technology have enhanced the
understanding and treatment of chronic diseases and led
to increased longevity [1]. In spite of this, chronic
diseases remain the leading cause of illness, disability
and death, not only in Australia, accounting for 90 % of
all deaths in 2011 [2], but also worldwide [3]. Given the
enormous personal, social and economic impact of chronic
diseases, tackling them has emerged as the predominant
challenge to global health [4]. It is well established that psy-
chosocial factors contribute significantly to the aetiology,
development and trajectory of chronic diseases, as well as
to quality of life [5, 6]. Even so, far too often psychosocial
aspects of chronic diseases are overlooked [7]. In a time
when medical breakthroughs equate to increased human
lifespan, essential now are effective (including cost-
effective) and sustainable interventions that target the
management of chronic disease.
An optimal health programme (OHP) that adopts a
person-centred approach and comprises psychosocial
supports and a skill base designed to maintain optimal
chronic disease management was originally designed to
support patients with mental illness [8, 9]. The OHP is
based on a collaborative therapy framework sensitive to
service structure, resources and staff mix to ensure
maximum likelihood of integration into existing health
services [10]. With the intention of enhancing self-
efficacy, self-management, care coordination and quality
of life the OHP has been adapted to the broader context
of chronic physical diseases. This commentary supple-
ments a series of study protocols of randomised
controlled trials that will evaluate the OHP across three
of the most significant contributors to disease burden:
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diabetes mellitus (DM), chronic kidney disease (CKD)
and stroke [11].
The chronic disease challenge
It is widely acknowledged that many chronic diseases,
particularly lifestyle-related diseases, share similarities in
their underlying aetiology, risk factors and progression
[12]. Epidemiological studies have provided evidence of
strong associations between chronic physical illness and
an increased risk of mental illness [13, 14]. For example,
links have been identified between anxiety and depression
and DM [15], CKD [16] and stroke [17]. Recognition of
these parallels and commonalities provides merit for a
holistic approach to chronic disease management that
targets psychosocial empowerment, collaborative care and
health service integration—the primary foci of the OHP.
Diabetes mellitus
The prevalence of DM is reported to have reached
epidemic proportions [18, 19]. The management of DM
imposes a complex self-care regimen that can be difficult
to sustain, including healthy eating, regular physical
activity, taking medications as recommended, checking
blood glucose levels and attending medical appoint-
ments. Owing to the evolving nature of DM and the
complex interactions it involves between physiological,
psychological and environmental factors, DM is
acknowledged to be one of the most challenging chronic
diseases [20, 21]. Recent guidelines have recommended a
collaborative approach to be delivered by a multidiscip-
linary team that tailors interventions to each individual’s
situation [22]. Thus, interventions involving shared
decision-making, pragmatic problem-solving and pro-
motion of behaviour change strategies should be consid-
ered when working toward achieving sustainable self-
management of DM.
Chronic kidney disease
The past two decades have seen a rapid escalation in the
prevalence of CKD due to an ageing population and a
growing prevalence of diabetes, hypertension and obesity
[23]. Recent estimates indicate that the cumulative costs
of providing treatment to new and existing patients in
Australia from 2009 to 2020 will reach $12 billion [24].
A recent review of CKD self-management programmes
concluded that life contexts, socioeconomic factors,
health literacy and psychological factors, as well as
communication with health care providers, all contribute
to an individual’s adherence to treatment, and further
that self-efficacy skill-building could potentially improve
treatment adherence [25]. Of note, CKD is largely a pre-
ventable chronic condition, as many of its risk factors are
modifiable, including high blood pressure, tobacco smok-
ing, physical inactivity, poor nutrition and obesity [24].
Stroke
Stroke is the second leading cause of death worldwide
(11 %) and is often associated with long-term disability
[26]. The abrupt onset of stroke and its numerous serious
sequelae profoundly affect the psychological health and
quality of life of stroke survivors and their carers [27, 28].
Role reversals and unexpected physical, cognitive and
emotional demands have been demonstrated to contribute
to adverse outcomes such as anxiety, depression, cardio-
vascular disease and mortality for both survivors and
carers [27–29]. Only recently has research in the field of
stroke shifted from a physical emphasis to include psycho-
logical and social elements with a focus on carers; yet, the
stroke survivor-carer dyad has received minimal attention
[30]. In recognition of the indispensable role of caregivers
in the management and co-ordination of care, often at the
expense of their own health, the stroke OHP has been de-
veloped in consideration of the needs of both stroke survi-
vors and their carers.
The Optimal Health Program (OHP)
This series of randomised controlled trials compose the
Translating Research, Integrated Public Health Outcomes
and Delivery (TRIPOD) programme of research. Within
TRIPOD, the OHP embraces a modular format that has
been tailored specifically to various stages of each of the
three chronic diseases, engaging consumers and clinicians
from acute care through to community. Figure 1 presents
a generic diagram of the OHP; descriptions of OHP mod-
ules specific to DM, CKD and stroke are presented in each
of the respective protocol papers. In brief, the modules
delivered by health care facilitators (e.g., nurse, psycholo-
gist) are based on a structured workbook/journal,
conducted weekly and approximately 1 h in duration.
Session 1 explores chronic disease and self-management
from a holistic perspective, incorporating social, physical,
emotional, intellectual, employment and spiritual aspects.
Sessions 2 and 3 see the introduction of a health plan
involving psychosocial implications and engagement with
health care providers. Session 4 is focused on medication
management and physical health. Session 5 helps to
identify and include key community supports. Session 6
establishes new proactive avenues for change, and session
7 integrates these via goal-setting around the complexities
of chronic disease. Session 8 strategizes sustainable
advance care planning. A ‘booster session’ is run 3 months
after session 8 to review progress against health plans.
When delivering the OHP, emphasis is placed on a
collaborative partnership between the facilitator and the
participant, who work together to develop viable health
action plans and to discuss and arrange referrals with
the multidisciplinary team, dependent on ongoing
caregiver needs. The facilitator encourages the partici-
pant to identify early warning signs of stress and
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illness and provides them with the skills to integrate
healthy coping strategies to successfully manage
stressful periods. Importantly, enhancing self-efficacy
is at the centre of the programme with the aim of
improving self-management skills, optimising psycho-
social health and increasing the capacity to access key
supports. By providing enablers for increased inde-
pendence and empowerment, we envisage that users
of the OHP will work towards a shift in focus from
the person being ‘dependent on’ services to being
‘supported by’ services.
Conclusions
The devastating effects of chronic disease not only
impact upon public health but also cause much harm to
the socioeconomic fabric of communities [31]. In the
absence of evidence-based and cost-effects models for
the management of chronic diseases, the human, social
and economic costs will continue to escalate and over-
whelm the capacity to address them [32]. Furthermore,
the growing understanding that many chronic diseases
arise from similar underlying causes and have similar
features challenges health care professionals to
Fig. 1 Translating Research, Integrated Public Health Outcomes and Delivery (TRIPOD) generic optimal health programme
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transform the way in which they respond to manage-
ment of these diseases. In this series of randomised con-
trolled trials, we will adapt a generic OHP for three
chronic diseases known to have the greatest impact on
disease burden: DM, CKD and stroke. In doing so, we
will attempt to address the challenge of effective and
sustainable chronic disease management via an OHP
that (1) has been developed in close collaboration with
health care clinicians, patients and carers; (2) addresses
psychological, social and physiological aspects of care;
(3) provides enablers for increased independence and
empowerment; and (4) incorporates a comprehensive
health economic cost analysis. The findings derived from
these trials will provide evidence for the efficacy and
feasibility of our OHP to be delivered across a far greater
range of chronic conditions.
Abbreviations
CKD: Chronic kidney disease; DM: Diabetes mellitus; OHP: Optimal Health
Program; TRIPOD: Translating Research, Integrated Public Health Outcomes
and Delivery;
Acknowledgements
This work was supported through the Australian government’s Collaborative
Research Networks (CRN) program. The OHP was developed at the Mental
Health Research Institute from 2001 to 2007 and at St. Vincent’s Hospital
from 2007 through the present.
Authors’ contributions
CFS drafted the manuscript. DJC and DRT made significant contributions and
edits to the commentary and approved the final manuscript. All authors
made substantial contributions to the conception and design of the trials.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Centre for the Heart and Mind, Australian Catholic University, Melbourne,
VIC 3000, Australia. 2Department of Psychiatry, University of Melbourne,
Melbourne, VIC 3010, Australia. 3Mental Health Service, St. Vincent’s Hospital,
Melbourne, VIC 3065, Australia.
Received: 7 October 2015 Accepted: 20 August 2016
References
1. Lichtenberg FR. The quality of medical care, behavioral risk factors, and
longevity growth. Int J Health Care Finance Econ. 2009;11:1–34.
2. Australian Institute of Health and Welfare (AIHW). Key indicators of progress
for chronic disease and associated determinants: data report. Catalogue
number PHE 142. Canberra, Australia: AIHW; June 2011. http://www.aihw.
gov.au/WorkArea/DownloadAsset.
aspx?id=10737419243&libID=10737419242. Accessed 30 Aug 2016.
3. Global Burden of Disease Study 2013 Collaborators. Global, regional, and
national incidence, prevalence, and years lived with disability for 301 acute
and chronic diseases and injuries in 188 countries, 1990–2013: a systematic
analysis for the Global Burden of Disease Study 2013. Lancet.
2015;386:743–800.
4. Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic
disease in the 21st century: elimination of the leading preventable
causes of premature death and disability in the USA. Lancet.
2014;384:45–52.
5. Schneiderman N, Antoni MH, Saab PG, Ironson G. Health psychology:
psychosocial and biobehavioral aspects of chronic disease management.
Annu Rev Psychol. 2001;52:555–80.
6. Tran MW, Weiland TJ, Phillips GA. Psychosocial and nonclinical factors predicting
hospital utilization in patients of a chronic disease management program: a
prospective observational study. J Ambul Care Manage. 2015;38:77–86.
7. Perruccio AV, Katz JN, Losina E. Health burden in chronic disease:
multimorbidity is associated with self-rated health more than medical
comorbidity alone. J Clin Epidemiol. 2012;65:100–6.
8. Castle D, White C, Chamberlain J, Berk M, Berk L, Lauder S, et al.
Group-based psychosocial intervention for bipolar disorder: randomised
controlled trial. Br J Psychiatry. 2010;196:383–8.
9. Gilbert MM, Chamberlain JA, White CR, Mayers PW, Pawsey B, Liew D, et al.
Controlled clinical trial of a self-management program for people with
mental illness in an adult mental health service – the Optimal Health
Program (OHP). Aust Health Rev. 2012;36:1–7.
10. Castle DJ, Gilbert M. Collaborative therapy: framework for mental health.
Br J Psychiatry. 2006;189:467.
11. World Health Organisation (WHO). Global status report on noncommunicable
diseases 2010. Geneva, Switzerland: WHO; 2011. http://www.who.int/nmh/
publications/ncd_report_full_en.pdf. Accessed 30 Aug 2016.
12. Sagner M, Katz D, Egger G, Lianov L, Schulz KH, Braman M, et al. Lifestyle
medicine potential for reversing a world of chronic disease epidemics: from
cell to community. Int J Clin Pract. 2014;68:1289–92.
13. Chapman DP, Perry GS, Strine TW. The vital link between chronic
disease and depressive disorders. Prev Chronic Dis [serial online]. 2005;
2(1):1. http://www.cdc.gov/pcd/issues/2005/jan/04_0066.htm. Accessed
30 Aug 2016.
14. Di Benedetto M, Lindner H, Aucote H, Churcher J, McKenzie S, Croning
N, et al. Co-morbid depression and chronic illness related to coping
and physical and mental health status. Psychol Health Med.
2014;19:253–62.
15. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association
of depression and diabetes complications: a meta-analysis. Psychosom Med.
2001;63:619–30.
16. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management
of depression in patients with CKD. Am J Kidney Dis. 2009;54:741–52.
17. Whyte EM, Mulsant BH. Post stroke depression: epidemiology,
pathophysiology, and biological treatment. Biol Psychiatry. 2002;52:253–64.
18. Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century.
Adv Exp Med Biol. 2012;771:42–50.
19. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
20. Long GH, Johansson I, Rolandsson O, Wennberg P, Fharm E, Weinehall L,
et al. Healthy behaviours and 10-year incidence of diabetes: a population
cohort study. Prev Med. 2015;71:121–7.
21. Soni A, Ng SM. Intensive diabetes management and goal setting are key
aspects of improving metabolic control in children and young people with
type 1 diabetes mellitus. World J Diabetes. 2014;5:877–81.
22. Craig ME, Twigg SM, Donaghue KC, Cheung NW, Cameron FJ, Conn J, et al.
Australian Type 1 Diabetes Guidelines Expert Advisory Group. National
evidence-based clinical care guidelines for type 1 diabetes in children,
adolescents and adults. Canberra, Australia: Australian Government,
Department of Health and Ageing; 2011. https://diabetessociety.com.au/
downloads/Type1guidelines(7Feb11).pdf. Accessed 30 Aug 2016.
23. Chen T, Harris DC. Challenges of chronic kidney disease prevention. Med J
Austral. 2015;203:209–10.
24. Australian Institute of Health and Welfare (AIHW). Projections of the prevalence
of treated end-stage kidney disease in Australia 2012–2020. Catalogue number
PHE 176. Canberra, Australia: AIHW; 2014. http://www.aihw.gov.au/WorkArea/
DownloadAsset.aspx?id=60129547200. Accessed 30 Aug 2016.
25. Bonner A, Havas K, Douglas C, Thepha T, Bennett P, Clark R. Self-management
programmes in stages 1–4 chronic kidney disease: a literature review. J Ren
Care. 2014;40:194–204.
26. Mendis S, Puska P, Norrving B, editors. Global atlas on cardiovascular
disease prevention and control. Geneva, Switzerland: World Health
Organisation; 2011.
27. Ski C, O’Connell B. Stroke: the increasing complexity of carer needs.
J Neurosci Nurs. 2007;39:172–9.
28. Kniepmann K. Female family carers for survivors of stroke: occupational loss
and quality of life. Br J Occup Ther. 2012;75:208–16.
29. Kirkevold M, Bronken BA, Martinsen R, Kvigne K. Promoting psychosocial
well-being following a stroke: developing a theoretically and empirically
sound complex intervention. Int J Nurs Stud. 2012;49:386–97.
Ski et al. Trials  (2016) 17:445 Page 4 of 5
30. Godwin KM, Ostwald SK, Cron SG, Wasserman J. Long-term health-related
quality of life of stroke survivors and their spousal caregivers. J Neurosci
Nurs. 2013;45:147–54.
31. Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med.
2013;369:1336–43.
32. Arredondo A, Aviles R, Clement F. Costs and Epidemiological Changes of
Chronic Diseases: Implications and Challenges for Health Systems. PLoS One
2015;10(3):e0118611.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ski et al. Trials  (2016) 17:445 Page 5 of 5
